The observed functional activity of NK cells within the tumour was reduced, reflecting a dominant inhibitory phenotype, also accompanied by enrichment for PD-1+ TIGIT+ NK cells and a reduction in CD16, a receptor capable to bind the antibody Fc fragment, thus enabling NK cells to perform ADCC. The gene discussed is TIGIT; the disease is neoplasm.